David Baker's lab at the University of Washington is announcing two major leaps in the field of AI-powered protein design.

Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, ...

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

Many people stop taking cholesterol-lowering statins because they experience muscle aches, weakness, and fatigue.

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...

A research team at Sejong University's Plant Immunity Laboratory, led by Professor Nam-Soo Jwa, has uncovered an important ...

The University of Cincinnati's LDDL trains the next generation of researchers and develops new blood cancer treatments.

Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell ...